Participants 223 319 6
21 patients with coronary artery disease who were receiving placebo, acebutolol, and propranolol
Participants 513 553 4
26 patients with chronic angina pectoris
Participants 981 1020 3
13 patients with stable angina pectoris
Participants 1272 1341 3
patients with coronary disease and a wide range of ejection fractions
